INNOVOTEX Announces Company Overview to Highlight Advancement of NOVO-111 and Macrocycle Drug Conjugate Platform
AUSTIN, TX, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- INNOVOTEX today announced an upcoming company overview focused on the continued advancement of its proprietary Macrocycle Drug Conjugate (MDC) platform and lead therapeutic candidate, …